Compile Data Set for Download or QSAR
Found 9387 with Last Name = 'tanner' and Initial = 'h'
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151989(US8987457, 183)copy SMILEScopy InChI
Affinity DataIC50: 0.0100nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151905(US8987457, 99)copy SMILEScopy InChI
Affinity DataIC50: 0.0100nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151889(US8987457, 83)copy SMILEScopy InChI
Affinity DataIC50: 0.0100nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151870(US8987457, 64)copy SMILEScopy InChI
Affinity DataIC50: 0.0100nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151959(US8987457, 153)copy SMILEScopy InChI
Affinity DataIC50: 0.0100nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM87369(US10245267, Example 704 | US10709712, Example 704 ...)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:C-Raf TR refers to a truncated C-Raf protein, a Δ1-324 deletion mutant.C-Raf FL refers to the full-length C-Raf protein.Full length MEK1 with an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2280BP3US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151879(US8987457, 73)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM87369(US10245267, Example 704 | US10709712, Example 704 ...)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMpH: 7.5 T: 2°CAssay Description:Raf and biotinylated Mek, kinase dead, were combined at 2x final concentrations in assay buffer (50 mM Tris, pH 7.5, 15 mM MgCl2, 0.01% BSA and 1 mM ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MC8X6WUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151972(US8987457, 166)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151977(US8987457, 171)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151980(US8987457, 174)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151982(US8987457, 176)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151990(US8987457, 184)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151901(US8987457, 95)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151907(US8987457, 101)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151924(US8987457, 118)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151941(US8987457, 135)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151943(US8987457, 137)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151945(US8987457, 139)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151946(US8987457, 140)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151947(US8987457, 141)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151948(US8987457, 142)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151950(US8987457, 144)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151952(US8987457, 146)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151954(US8987457, 148)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151965(US8987457, 159)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151967(US8987457, 161)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151971(US8987457, 165)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151839(US8987457, 33)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151862(US8987457, 56)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151864(US8987457, 58)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
NOVARTIS AG

US Patent
LigandPNGBDBM87369(US10245267, Example 704 | US10709712, Example 704 ...)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMAssay Description:Raf and biotinylated Mek, kinase dead, were combined at 2× final concentrations in assay buffer (50 mM Tris, pH 7.5, 15 mM MgCl2, 0.01% BSA and 1 mM ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2RB76WPUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151953(US8987457, 147)copy SMILEScopy InChI
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151893(US8987457, 87)copy SMILEScopy InChI
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151985(US8987457, 179)copy SMILEScopy InChI
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151987(US8987457, 181)copy SMILEScopy InChI
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151999(US8987457, 193)copy SMILEScopy InChI
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151900(US8987457, 94)copy SMILEScopy InChI
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151908(US8987457, 102)copy SMILEScopy InChI
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151923(US8987457, 117)copy SMILEScopy InChI
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151929(US8987457, 123)copy SMILEScopy InChI
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151936(US8987457, 130)copy SMILEScopy InChI
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151944(US8987457, 138)copy SMILEScopy InChI
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151894(US8987457, 88)copy SMILEScopy InChI
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151811(US8987457, 5)copy SMILEScopy InChI
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151855(US8987457, 49)copy SMILEScopy InChI
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151867(US8987457, 61)copy SMILEScopy InChI
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151868(US8987457, 62)copy SMILEScopy InChI
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151872(US8987457, 66)copy SMILEScopy InChI
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM151878(US8987457, 72)copy SMILEScopy InChI
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2765D2MUS Patent
Displayed 1 to 50 (of 9387 total ) | Next | Last >>
Jump to: